ANTIGEN EXPRESSION IN XENOTRANSPLANTATION: HOW LOW MUST IT GO?
- 1 January 2001
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 71 (2), 313-319
- https://doi.org/10.1097/00007890-200101270-00025
Abstract
Acute vascular rejection (AVR) is an important immunological barrier to xenotransplantation. Thought to be initiated by xenoreactive antibodies, acute vascular rejection might, in principle, be avoided by engineering animals to express low levels of antigen. The extent to which antigen expression would have to be decreased to achieve such a goal is unknown. We estimated the decrease in expression of a xenogeneic antigen, Galalpha1-3Gal, which might be needed to avert acute vascular rejection of xenotransplants based on the decrease in antibody binding to endothelium that would prevent tissue damage. The level of decrease needed in Galalpha1-3Gal expression needed to avoid acute vascular rejection was estimated to exceed 96% of baseline. The extent of the decrease needed reflected, in part, a substantial "excess" of Galalpha1-3Gal on porcine endothelial cell surfaces. Although the change in antigen expression required to avoid acute vascular rejection might be conditioned by various factors, the very large magnitude of this change necessitates application of highly efficient approaches to antigen modification.Keywords
This publication has 27 references indexed in Scilit:
- DEMONSTRATION OF IgM ANTIBODIES OF HIGH AFFINITY WITHIN THE ANTI-GAL??1-3GAL ANTIBODY REPERTOIRETransplantation, 1998
- ANTI-Gal??1-3Gal ANTIBODY RESPONSE TO PORCINE BONE MARROW IN UNMODIFIED BABOONS AND BABOONS CONDITIONED FOR TOLERANCE INDUCTION1Transplantation, 1998
- The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants.JCI Insight, 1998
- Delayed xenograft rejectionImmunology Today, 1996
- Transplantation of discordant xenografts: a challenge revisitedImmunology Today, 1996
- Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation.JCI Insight, 1995
- THE HUMORAL IMMUNE RESPONSE IN HUMANS FOLLOWING CROSS-PERFUSION OF PORCINE ORGANSTransplantation, 1995
- INCREASED ANTI-GAL ACTIVITY IN DIABETIC PATIENTS TRANSPLANTED WITH FETAL PORCINE ISLET CELL CLUSTERSTransplantation, 1995
- VARIATION IN THE LEVEL OF XENOANTIGEN EXPRESSION IN PORCINE ORGANSTransplantation, 1995
- VARIATION IN EXPRESSION OF PORCINE XENOGENEIC ANTIGENSTransplantation, 1994